US 7354581
Therapeutic combination of a VEGF antagonist and anti-hypertensive agent
granted A61KA61K31/138A61K31/355
Quick answer
US patent 7354581 (Therapeutic combination of a VEGF antagonist and anti-hypertensive agent) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/138, A61K31/355, A61K31/401, A61K31/403